Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.
Citations
1,076 citations
1,013 citations
810 citations
Cites background from "Insomnia with objective short sleep..."
...Another recent discovery concerns differences between insomnia with, and without, an objective short sleep duration (Fernandez-Mendoza, 2017; Vgontzas et al., 2013)....
[...]
730 citations
Cites background or result from "Insomnia with objective short sleep..."
...…insomnia with short sleep duration are more likely to show increases in urinary catecholamines and levels of their metabolites than are insomniacs without objective sleep disturbance, similar to the greater activation of inflammatory biomarkers in this more severe phenotype (Vgontzas et al. 2013)....
[...]
...…measured by blood pressure, heart rate variability, and impedance cardiography) are found in patients with insomnia (Bonnet & Arand 1997, De Zambotti et al. 2011, Lanfranchi et al. 2009, Riemann 2010, Vgontzas et al. 2013) and following sleep deprivation (Irwin et al. 1999, Irwin & Ziegler 2005)....
[...]
...In contrast, chronic sleep disturbance leads to activation of the HPA and SNS pathways (Vgontzas et al. 2013), which together contribute to an increased proinflammatory and reduced antiviral skewing of the basal gene expression profile, termed the basal transcriptome....
[...]
...…with compelling evidence that disturbances of sleep including insomnia complaints and extremes of sleep duration adversely influence risk of infectious and inflammatory disease and contribute to allcause mortality (Dew et al. 2003, Kripke et al. 2002, Mallon et al. 2002, Vgontzas et al. 2013)....
[...]
...Those who report sleep complaints and/or have short sleep duration appear to be at greatest risk of cardiovascular disease (Vgontzas et al. 2013)....
[...]
616 citations
References
4,004 citations
3,696 citations
3,322 citations
3,112 citations